Title : AMPK attenuates bupivacaine-induced neurotoxicity.

Pub. Date : 2010 Aug

PMID : 20448244






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AMPK attenuates bupivacaine-induced neurotoxicity. Bupivacaine protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
2 We hypothesized that AMPK may be cytoprotective in bupivacaine-treated Schwann cells. Bupivacaine protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
3 The expression of phosphorylated AMPK was compared after bupivacaine treatment. Bupivacaine protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
4 Bupivacaine induced cell death in a time- and dose- [50% lethal dose (LD(50)) = 316 microM] dependent manner, and increased expression of phosphorylated AMPK after bupivacaine treatment. Bupivacaine protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
5 Bupivacaine induced cell death in a time- and dose- [50% lethal dose (LD(50)) = 316 microM] dependent manner, and increased expression of phosphorylated AMPK after bupivacaine treatment. Bupivacaine protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
6 Bupivacaine-induced cytotoxicity was attenuated by AICAR (an AMPK activator), whereas compound C (an AMPK inhibitor) enhanced it. Bupivacaine protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
7 Our results suggest that the AMPK pathway may protect Schwann cells from bupivacaine-induced cytotoxicity. Bupivacaine protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus